11.39USD+0.18%Mkt Cap: 1.20B USDP/E: —Last update: 2026-06-01
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of mi…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap1.20B USD
Enterprise Value998.34M USD
Revenue (TTM)64.52M USD
Gross Profit15.78M USD
Net Income (TTM)-81.27M USD
Revenue/Share0.6910 USD
Last Price11.39 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees259
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.73
PEG—
EV/EBITDA-10.77
EV/Revenue15.47
P/S18.50
P/B4.69
EPS (TTM)-1.02
EPS (Forward)-0.90
52W Range
3.84094% of range11.85
52W High11.85 USD
52W Low3.840 USD
Profitability
Gross Margin22.65%
Oper. Margin-207.87%
EBITDA Margin-143.68%
Profit Margin-116.69%
ROE-31.12%
ROA-24.32%
Growth
Revenue Growth-24.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-74.95M USD
CapEx (TTM)4.50M USD
FCF Margin-65.65%
FCF Yield-3.53%
Net Debt-194.44M USD
Net Debt/EBITDA2.10
Balance Sheet
Debt/Equity0.15
Current Ratio6.61
Quick Ratio6.31
Book Value/Sh2.433 USD
Cash/Share2.227 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)10.86 USD
Target Range9.000 USD – 13.00 USD
# Analysts7
Ownership
Shares Out.104.72M
Float62.47M
Insiders27.05%
Institutions70.12%
Short Interest
Short Ratio5.8d
Short % Float20.71%
Short % Out.13.12%
Shares Short13.73M
Short (prev mo.)12.39M
Technical
SMA 506.797 (+67.6%)
SMA 2007.666 (+48.6%)
Beta1.97
S&P 52W Chg27.70%
Avg Vol (30d)2.53M
Avg Vol (10d)2.90M
Technical Indicators
RSI (14)84.4
MACD1.0406
MACD Signal0.5129
MACD Hist.+0.5277
BB Upper10.80 USD
BB Middle7.286 USD
BB Lower3.776 USD
BB Width96.37%
ATR (14)0.7417 USD
Vol Ratio (20d)1.08x